Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer.
Hino K, Nishina T, Numata Y, Asagi A, Inoue T, Yoshimatsu M, Sakaguchi C, Nakasya A, Nishide N, Kajiwara T, Terao T, Nadano S, Marui K, Okujima Y, Kokubu M, Imamura Y, Kanemitsu K, Koizumi M, Kumagi T, Hiasa Y, Hyodo I. Hino K, et al. Among authors: terao t. Intern Med. 2022;61(15):2255-2261. doi: 10.2169/internalmedicine.8736-21. Epub 2022 Aug 1. Intern Med. 2022. PMID: 35908959 Free PMC article.
Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients.
Kuroda T, Kumagi T, Yokota T, Azemoto N, Hasebe A, Seike H, Nishiyama M, Inada N, Shibata N, Miyata H, Kawamura T, Imai Y, Ueno-Toshimori A, Tanaka Y, Terao T, Imamura Y, Koizumi M, Yamanishi H, Ohno Y, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group. Kuroda T, et al. Among authors: terao t. BMC Gastroenterol. 2017 May 22;17(1):66. doi: 10.1186/s12876-017-0623-8. BMC Gastroenterol. 2017. PMID: 28532457 Free PMC article. Review.
Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance.
Kumagi T, Terao T, Yokota T, Azemoto N, Kuroda T, Imamura Y, Uesugi K, Kisaka Y, Tanaka Y, Shibata N, Koizumi M, Ohno Y, Yukimoto A, Tange K, Nishiyama M, Kanemitsu K, Miyake T, Miyata H, Ishii H, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group. Kumagi T, et al. Among authors: terao t. Mayo Clin Proc. 2019 Oct;94(10):2004-2010. doi: 10.1016/j.mayocp.2018.12.034. Epub 2019 Jun 28. Mayo Clin Proc. 2019. PMID: 31262521 Free article.
ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer.
Tanaka Y, Kumagi T, Terao T, Kuroda T, Yokota T, Azemoto N, Imamura Y, Uesugi K, Kisaka Y, Shibata N, Koizumi M, Ohno Y, Kanemitsu K, Yukimoto A, Tange K, Nishiyama M, Miyake T, Miyata H, Ishii H, Abe M, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group. Tanaka Y, et al. Among authors: terao t. Intern Med. 2020;59(6):761-768. doi: 10.2169/internalmedicine.3748-19. Epub 2020 Mar 15. Intern Med. 2020. PMID: 32173688 Free PMC article.
Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer.
Terao T, Kumagi T, Hyodo I, Yokota T, Azemoto N, Miyata H, Kuroda T, Ohno Y, Tanaka Y, Shibata N, Imamura Y, Kanemitsu K, Miyake T, Koizumi M, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group. Terao T, et al. Medicine (Baltimore). 2021 Oct 29;100(43):e27591. doi: 10.1097/MD.0000000000027591. Medicine (Baltimore). 2021. PMID: 34713835 Free PMC article.
Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate.
Kumagi T, Terao T, Kuroda T, Koizumi M, Imamura Y, Ohno Y, Yokota T, Azemoto N, Uesugi K, Kisaka Y, Tanaka Y, Shibata N, Miyata H, Miyake T, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group. Kumagi T, et al. Among authors: terao t. Cancers (Basel). 2023 Jan 17;15(3):561. doi: 10.3390/cancers15030561. Cancers (Basel). 2023. PMID: 36765521 Free PMC article.
Oral Inflammation and Microbiome Dysbiosis Exacerbate Chronic Graft-versus-host Disease.
Kambara Y, Fujiwara H, Yamamoto A, Gotoh K, Tsuji S, Kunihiro M, Oyama T, Terao T, Sato A, Tanaka T, Peltier D, Seike K, Nishimori H, Asada N, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Soga Y, Reddy P, Maeda Y. Kambara Y, et al. Among authors: terao t. Blood. 2024 Dec 18:blood.2024024540. doi: 10.1182/blood.2024024540. Online ahead of print. Blood. 2024. PMID: 39693612
906 results